New research collaboration on liver health with 3 research groups of the Department
Schwabe Pharma group launched a strategic research collaboration which aims to advance development of innovative therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - one of the fastest-growing challenges in liver health worldwide.